Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Research and development - MRTP

Sales, general and administrative

Impairment of intangible assets

Depreciation

Amortization

Other operating expense, net

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

22nd Century Group

22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

22nd Century Group advances VLN and GVB units towards profitability

22nd Century Group's Q4 2022 earnings call highlighted progress in VLN tobacco and GVB hemp/cannabis units, with plans for multi-state launches and cash positive operations in 2024. Despite challenges like the Grass Valley facility fire, the company remains focused on achieving profitability through revenue growth and market expansion. Key strengths include successful pilot results, volume growth, and a clear path to cash positivity for both business units.

22nd Century Group (XXII) reports strong Q1 performance and growth strategies

22nd Century Group (XXII) showcases strong performance and strategic initiatives to drive revenue growth and achieve cash positivity by 2024.
Despite challenges such as analyst inquiries and insurance impacts, the company's focus on cost efficiencies and margin improvements positions it for success.
Opportunities in revenue growth, bulk ingredient capacity expansion, and margin enhancements present promising prospects for future profitability and market growth.

22nd Century Group reports strong Q2 performance amidst operational challenges

22nd Century Group's Q2 performance showcased growth in sales but faced challenges in gross profit due to production mix shifts.
The company's proactive strategies for cost savings, brand value creation, and gross margin improvement indicate a focus on long-term sustainability.
Despite challenges like VLN rollout delays and tobacco business hurdles, opportunities in market differentiation and efficiency improvements are being pursued.

22nd Century Group pursues profitability through strategic shifts and cost management

22nd Century Group's Q4 2023 earnings call highlighted efforts to achieve profitability by reducing cash burn, focusing on VLN cigarettes for harm reduction, and exploring CMO opportunities in tobacco manufacturing. Despite challenges like decreased net sales and a negative gross profit, the company aims to reach breakeven by Q1 2025.

22nd Century Group reduces cash burn, aims for profitability by 2025

22nd Century Group's Q1 2024 performance reflects progress towards profitability, with improved financial discipline and operational efficiency.
While facing revenue challenges and legal disputes, the company's strategic initiatives and investor support position it for future growth and success.
The focus on reducing losses, strengthening the balance sheet, and expanding market presence underscores the company's commitment to long-term sustainability.

22nd Century Group reports Q2 financial turnaround and growth strategies

22nd Century Group's Q2 2024 performance reflects a notable financial turnaround and progress towards profitability.
Strategic initiatives, leadership appointments, and product strategies position the company for future growth and success.
While challenges remain in achieving cash positive operations, opportunities in market expansion and product innovation offer avenues for continued advancement.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

22nd Century Group (XXII) expands its VLN offerings in Montana by adding Town Pump convenience stores to its product distribution channel.

22nd Century Group (XXII) Boosts VLN Offerings in Montana

With 95% less nicotine than a traditional cigarette, VLN® cigarettes help existing adult smokers reduce their nicotine consumption and dependence With 95% less nicotine than a traditional cigarette, VLN® cigarettes help existing adult smokers reduce their nicotine consumption and dependence

A Cigarette to Help Californians Smoke Less: 22nd Century Group, Inc. Launches Reduced Nicotine VLN® King Cigarettes in California, VLN Will Be Sold at #1 U.S. Convenience Store Chain and Other Responsible Retail Locations

Blue Apron

OrganiGram Holdings Inc.

Stock Split is a regular occurrence within the stock market. However, they are much more common among stocks at risk of being delisted from an exchange such as NASDAQ due to minimum bid requirements that revolve around a company's share price.

3 Doomed Stock-Split Stocks Destined for Disaster

Town Pump, #1 Chain in Montana, Selling VLN® Products in More Than 80 Stores Across the State

22nd Century Group (XXII) VLN® Products Now Selling in Montana C-Stores

BUFFALO, N.Y., July 12, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced a new distribution agreement with Hub, Inc., a key Midwest based convenience store (C-store) and multi-channel distributor with warehouses located in Missouri and Kansas.

22nd Century Group (XXII) Announces New Agreement with Hub, Inc. to Expand Midwest Distribution

Coherus BioSciences

KludeIn I Acquisition Corp

Ever heard of penny stocks? If you're new to investing, you might be scratching your head.

Best Penny Stocks To Buy Now? 3 To Watch Right Now

BUFFALO, N.Y., July 06, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it has entered into definitive agreements with certain investors for the purchase and sale of 778,634 shares of common stock and warrants at a price of $3.80 per share in a registered direct offering priced above market. Gross proceeds to the Company from the registered direct offering are expected to be $3.0 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for the continued commercial expansion of its VLN® reduced nicotine content tobacco cigarettes in additional markets, working capital related to its commercial activities and general corporate purposes.

22nd Century Announces $3.0 Million Registered Direct Offering Priced Above Market

22nd Century Group is a mispriced agricultural biotechnology company that is poised to transform the global tobacco and hemp/cannabis markets. Shares are down 60% during the past month, as investors overlook compelling near-term catalysts and overestimate the potential for further equity dilution. An aggressive multistate product launch is underway for VLN, the only combustible cigarette to receive a modified risk tobacco product designation.

22nd Century Group: On The Path To Lighting Up Profitable Growth And Shareholder Returns

Re-Affirms Full-Year Outlook of $105 Million to $110 Million in Net Sales Re-Affirms Full-Year Outlook of $105 Million to $110 Million in Net Sales

22nd Century Announces 1-for-15 Reverse Stock Split

HTL Is Commonly Used in Heat-Not-Burn and Cigar Binder and Wrapper Applications Provides VLN® Tobacco Solution in Large Adjacent Markets BUFFALO, N.Y., June 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced it has successfully produced homogenized tobacco leaf (HTL) sheet using VLN® reduced nicotine content tobacco, demonstrating a reduced nicotine content pathway for additional large markets such as heat-not-burn products and as the binder or wrapper for machine-made cigars.

22nd Century Group (XXII) Announces Production of VLN® Homogenized Tobacco Leaf Sheet

Altria

Philip Morris

The Zacks Tobacco industry players gain from their pricing power and focus on smoke-free products amid cost inflation and low cigarette volumes. Philip Morris (PM), Altria Group (MO) and 22nd Century Group (XXII) look well-placed.

Watch These 3 Tobacco Stocks on Favorable Industry Trends

Terrible Herbst and Speedee Mart Selling VLN® Reduced Nicotine Products in Approximately 200 Las Vegas Area Stores FDA Authorized VLN® Products Are Specifically Designed to Reduce the Harms of Smoking BUFFALO, N.Y., June 21, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced its FDA authorized VLN® reduced nicotine content cigarettes are now available in approximately 200 Las Vegas area Terrible Herbst and Speedee Mart convenience-stores (c-stores).

VLN® Products Launch in Nevada to Help Smokers Smoke Less

BJ`s Wholesale Club Holdings Inc

Campbell Soup

Lancaster Colony

Upexi Inc

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 5 Defensive Stocks That May Rocket Higher This Quarter

BUFFALO, N.Y., June 20, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it has entered into definitive agreements with certain investors for the purchase and sale of 11.2 million shares of common stock and warrants at a price of $0.47 per share in a registered direct offering priced above market.

22nd Century Announces $5.3 Million Registered Direct Offering Priced Above Market

Largest U.S. C-Store Chain Will Add VLN® to More Than 1,450 Corporate Stores in Three Largest State Markets, Incentivizes Additional 3,100 Franchise Stores to Join the Launch

22nd Century Group (XXII) Launching VLN® at #1 U.S. C-Store Chain in Texas, California and Florida

BUFFALO, N.Y., June 02, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced it will participate in the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, Los Angeles, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private one-on-one meetings.

22nd Century Group (XXII) Announces Participation in the LD Micro Invitational XIII

FDA Authorized VLN® Products from 22nd Century Group Provide Key Support to Menthol Ban and Reduced Nicotine Content Policies Currently Advancing in the U.S.

22nd Century Group (XXII) Highlights Recent TCORS Symposium Findings

22nd Century Group, Inc. (NASDAQ:XXII ) Q1 2023 Earnings Call May 9, 2023 10:00 AM ET Company Participants Matt Kreps - Investor Relations James A. Mish - Chief Executive Officer R.

22nd Century Group, Inc. (XXII) Q1 2023 Earnings Call Transcript

22nd Century Group (XXII) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.05 per share a year ago.

22nd Century Group (XXII) Reports Q1 Loss, Tops Revenue Estimates

BUFFALO, N.Y., May 09, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today reported results for the first quarter ended March 31, 2023, and provided an update on recent business highlights. The Company will host a live audio webcast today at 10:00 a.m. ET.

22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook

BUFFALO, N.Y., May 03, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Tuesday, May 9, 2023, at 10:00 AM ET to discuss its 2023 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day.

22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2023 Results on May 9, 2023

Second Leading Consumer Hemp/Cannabis Brand Adopts 22nd Century's Turn-Key Contract Development and Manufacturing Plus Distribution (CDMO+D) Solution

22nd Century Group (XXII) Announces Strategic License, Manufacturing and Distribution Agreement with Old Pal

Pinnacle Cigarette Brand to Be Sold in up to 1,700 U.S. Retail Locations in up to 27 States Dramatically Increases CDMO Revenue and Business Unit Profitability Toward Cash Positive, in Line with Recent Expectations Buffalo, New York--(Newsfile Corp. - April 18, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it has commenced sales under a new manufacturing agreement to produce a private label premium cigarette brand, Pinnacle, for sale at one of the nation's top-10 gas station convenience store chains, comprising almost 1,700 stores in 27 states. "We are excited to launch a new store-brand product with one of the largest convenience store chains in the country, and one of the highest volume cigarette points of sale per outlet square foot," stated John Miller, president of tobacco products at 22nd Century Group.

22nd Century Group Launches New Private Label Brand with Top U.S. C-Store Chain

Launches Turn-Key Contract Development and Manufacturing Plus Distribution (CDMO+D) Solution for Industry Leading Hemp/Cannabis Brands

22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies

22nd Century Group, Inc. (XXII) Q4 2022 Earnings Conference Call March 9, 2023 10:00 AM ET Corporate Participants Matt Kreps - Investor Relations Jim Mish - Chief Executive Officer John Miller - President, Tobacco Business Hugh Kinsman - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Vivien Azer - TD Cowen Alex Fuhrman - Craig-Hallum Capital Group Brian Wright - ROTH MKM Jim McIlree - Dawson James Operator Good day, ladies and gentlemen, and welcome to the 22nd Century Group's Fourth Quarter and Year-End Results Conference Call. At this time all lines are in a listen-only mode.

News for 22nd Century Group Stock (XXII)